BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33690887)

  • 1. Paediatric chronic myeloid leukaemia presenting in de novo or secondary blast phase - a comparison of clinical and genetic characteristics.
    Sembill S; Göhring G; Schirmer E; Lutterloh F; Suttorp M; Metzler M; Karow A
    Br J Haematol; 2021 May; 193(3):613-618. PubMed ID: 33690887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
    Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
    Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia.
    Millot F; Maledon N; Guilhot J; Güneş AM; Kalwak K; Suttorp M
    Eur J Cancer; 2019 Jul; 115():17-23. PubMed ID: 31082688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases.
    Merzianu M; Medeiros LJ; Cortes J; Yin C; Lin P; Jones D; Glassman A; Kantarjian H; Huh Y
    Am J Clin Pathol; 2005 Nov; 124(5):807-14. PubMed ID: 16203287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherin-13 in primary and blast crisis chronic myeloid leukaemia: declining expression and negative correlation with the BCR/ABL fusion gene.
    Mu HJ; Xie R; Shen YF; Jiang YQ; Zeng YJ
    Br J Biomed Sci; 2009; 66(1):20-4. PubMed ID: 19348122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia.
    Pullarkat ST; Vardiman JW; Slovak ML; Rao DS; Rao NP; Bedell V; Said JW
    Leuk Res; 2008 Nov; 32(11):1770-5. PubMed ID: 18417213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
    Chen Z; Shao C; Wang W; Zuo Z; Mou X; Hu SJ; DiGiuseppe JA; Zu Y; Medeiros LJ; Hu S
    Leukemia; 2017 Mar; 31(3):585-592. PubMed ID: 27560111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study.
    Meyran D; Petit A; Guilhot J; Suttorp M; Sedlacek P; De Bont E; Li CK; Kalwak K; Lausen B; Culic S; de Moerloose B; Biondi A; Millot F
    Eur J Cancer; 2020 Sep; 137():224-234. PubMed ID: 32799036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation.
    Soliman DS; Amer AM; Mudawi D; Al-Sabbagh Z; Alkuwari E; Al-Sabbagh A; Ibrahim F; Yassin MA
    Acta Biomed; 2018 Apr; 89(3-S):38-44. PubMed ID: 29633732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IKZF1 deletion and co-occurrence with other aberrations in a child with chronic myeloid leukemia progressing to acute lymphoblastic leukemia.
    Klumb CE; Barbosa TDC; Nestal de Moraes G; Schramm MT; Emerenciano M; Maia RC
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27570. PubMed ID: 30511400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase FISH for BCR-ABL1 rearrangement on neutrophils: A decisive tool to discriminate a lymphoid blast crisis of chronic myeloid leukemia from a de novo BCR-ABL1 positive acute lymphoblastic leukemia.
    Balducci E; Loosveld M; Rahal I; Boudjarane J; Alazard E; Missirian C; Lafage-Pochitaloff M; Michel G; Zattara H
    Hematol Oncol; 2018 Feb; 36(1):344-348. PubMed ID: 28444777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.
    Xu L; Lu Y; Lai J; Yu W; Zhang Y; Jin Z; Xu Y; Chen J; Zha X; Chen S; Yang L; Li Y
    Sci China Life Sci; 2015 Dec; 58(12):1276-81. PubMed ID: 26423566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-96 acts as a tumor suppressor via targeting the BCR-ABL1 oncogene in chronic myeloid leukemia blastic transformation.
    Huang T; Fu Y; Wang S; Xu M; Yin X; Zhou M; Wang X; Chen C
    Biomed Pharmacother; 2019 Nov; 119():109413. PubMed ID: 31518872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
    Matsunaga T; Naganuma K; Tabayashi T; Kawada T; Sakata N; Takahashi Y; Kimura Y; Anan T; Mitsuhashi T; Kubota Y; Sawada K; Yamashita T; Momose S; Higashi M; Tamaru JI; Kizaki M
    Rinsho Ketsueki; 2022; 63(12):1643-1647. PubMed ID: 36653137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of EVI1 transcription by the LEF1/β-catenin complex with p53-alteration in myeloid blast crisis of chronic myeloid leukemia.
    Manachai N; Saito Y; Nakahata S; Bahirvani AG; Osato M; Morishita K
    Biochem Biophys Res Commun; 2017 Jan; 482(4):994-1000. PubMed ID: 27908728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.
    Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D
    Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
    Nguyen PL; Arthur DC; Litz CE; Brunning RD
    Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.